antidiabetic agent
Troglitazone is a new thiazolidinedione oral antidiabetic agent approved for use        to improve glycaemic control in patients with type 2 diabetes.
Troglitazone is a new thiazolidinedione oral  @SUBJECT$  approved for use        to improve glycaemic control  @PREDICAT$   @OBJECT$  with type 2 diabetes.